Other
Exposure factors
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Other(3)
Detailed Status
unknown3
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
N/A
Trials by Status
not_yet_recruiting125%
unknown375%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruiting
Factor Associated With Mortality in the ICU
NCT07249749
unknown
A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B
NCT06041022
unknown
Non-invasive Monitoring and Serum Marker Study in Children With Cerebral Edema
NCT06017635
unknown
Retinol-binding Protein 4 (RBP4) Metabolizm in Type 2 Diabetes Progression and Associated Cardiovascular Complications
NCT04325126
Clinical Trials (4)
Showing 4 of 4 trials
NCT07249749
Factor Associated With Mortality in the ICU
NCT06041022
A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B
NCT06017635
Non-invasive Monitoring and Serum Marker Study in Children With Cerebral Edema
NCT04325126
Retinol-binding Protein 4 (RBP4) Metabolizm in Type 2 Diabetes Progression and Associated Cardiovascular Complications
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4